These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 16543537)

  • 1. Clinical insights into paraneoplastic cerebellar degeneration.
    Scheid R; Voltz R; Briest S; Kluge R; von Cramon DY
    J Neurol Neurosurg Psychiatry; 2006 Apr; 77(4):529-30. PubMed ID: 16543537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebellar hypermetabolism in paraneoplastic cerebellar degeneration.
    Choi KD; Kim JS; Park SH; Kim YK; Kim SE; Smitt PS
    J Neurol Neurosurg Psychiatry; 2006 Apr; 77(4):525-8. PubMed ID: 16543536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strategies in detection of the primary tumour in anti-Yo associated paraneoplastic cerebellar degeneration.
    Frings M; Antoch G; Knorn P; Freudenberg L; Bier U; Timmann D; Maschke M
    J Neurol; 2005 Feb; 252(2):197-201. PubMed ID: 15729526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A rare case of paraneoplastic cerebellar degeneration discovered by whole-body F-18 FDG PET.
    Rubello D; Vitaliani R; Rigoni MT; Rampin L; Giometto B; Casara D; Zonzin GC; Zavagno G; Capirci C; Shapiro B; Muzzio PC
    Clin Nucl Med; 2005 Oct; 30(10):704-6. PubMed ID: 16166852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paraneoplastic cerebellar degeneration preceding the diagnosis of Hodgkin's lymphoma.
    Ypma PF; Wijermans PW; Koppen H; Sillevis Smitt PA
    Neth J Med; 2006; 64(7):243-7. PubMed ID: 16929086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diffuse cerebellar MR imaging changes in anti-Yo positive paraneoplastic cerebellar degeneration.
    Gilmore CP; Elliott I; Auer D; Maddison P
    J Neurol; 2010 Mar; 257(3):490-1. PubMed ID: 19943166
    [No Abstract]   [Full Text] [Related]  

  • 7. Diagnosis of Dual Malignancy by 18F-FDG PET/CT in the Setting of Paraneoplastic Cerebellar Degeneration.
    Thapa P; Basu S
    J Nucl Med Technol; 2016 Mar; 44(1):52-3. PubMed ID: 26271804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain 18F-FDG-PET characteristics in patients with paraneoplastic neurological syndrome and its correlation with clinical and MRI findings.
    Masangkay N; Basu S; Moghbel M; Kwee T; Alavi A
    Nucl Med Commun; 2014 Oct; 35(10):1038-46. PubMed ID: 25023997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paraneoplastic cerebellar degeneration associated with cerebellar hypermetabolism: Case report.
    Abdulaziz ATA; Yu XQ; Zhang L; Jiang XY; Zhou D; Li JM
    Medicine (Baltimore); 2018 Jun; 97(24):e10717. PubMed ID: 29901574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paraneoplastic cerebellar degeneration in pediatric Hodgkin disease.
    Hahn A; Claviez A; Brinkmann G; Altermatt HJ; Schneppenheim R; Stephani U
    Neuropediatrics; 2000 Feb; 31(1):42-4. PubMed ID: 10774996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hodgkin lymphoma-associated paraneoplastic cerebellar degeneration on FDG-PET/CT.
    Gheysens O; Deroose CM; Tousseyn T; Goffin K; Verhoef G; Dierickx D
    Br J Haematol; 2014 Feb; 164(4):468. PubMed ID: 24460525
    [No Abstract]   [Full Text] [Related]  

  • 12. A rare gynecological case of paraneoplastic cerebellar degeneration discovered by FDG-PET.
    Marchand V; Graveleau J; Lanctin-Garcia C; Bourbouloux E; Bridji B; Resche I; Kraeber-Bodéré F; Rousseau C
    Gynecol Oncol; 2007 May; 105(2):545-7. PubMed ID: 17368524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebellar hypermetabolism on ¹⁸F-FDG PET/CT with normal MRI in a case of paraneoplastic cerebellar degeneration with negative antibodies.
    Sharma P; Mazumdar B; Chatterjee P
    Rev Esp Med Nucl Imagen Mol; 2015; 34(1):79-80. PubMed ID: 25001850
    [No Abstract]   [Full Text] [Related]  

  • 14. Anti-Yo mediated paraneoplastic cerebellar degeneration in the context of breast cancer: a case report and literature review.
    Key RG; Root JC
    Psychooncology; 2013 Sep; 22(9):2152-5. PubMed ID: 23585287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paraneoplastic cerebellar degeneration as the first manifestation of cancer.
    Lin JT; Lachmann E; Nagler W
    J Womens Health Gend Based Med; 2001 Jun; 10(5):495-502. PubMed ID: 11445049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case of slowly progressive anti-Yo-associated paraneoplastic cerebellar degeneration successfully treated with antitumor and immunotherapy].
    Tsuboguchi S; Yajima R; Higuchi Y; Ishikawa M; Kawachi I; Koyama Y; Nishizawa M
    Rinsho Shinkeigaku; 2016 Jul; 56(7):477-80. PubMed ID: 27356731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebellar degeneration and ocular myasthenia gravis in a patient with recurring ovarian carcinoma.
    Caliandro P; Luigetti M; Ricci E; Mirabella M; Tonali PA; Padua L
    Neurol Sci; 2010 Feb; 31(1):79-81. PubMed ID: 19806316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frontal executive impairment associated with paraneoplastic cerebellar degeneration: a case study.
    Collinson SL; Anthonisz B; Courtenay D; Winter C
    Neurocase; 2006 Dec; 12(6):350-4. PubMed ID: 17182399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paraneoplastic cerebellar degeneration: Yo-expressing tumor revealed after a 5-year follow-up with FDG-PET.
    Mathew RM; Cohen AB; Galetta SL; Alavi A; Dalmau J
    J Neurol Sci; 2006 Dec; 250(1-2):153-5. PubMed ID: 17011583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FDG PET Unveils the Course of Paraneoplastic Cerebellar Degeneration: A Semiquantitative Analysis.
    Massa F; Filippi L; Benedetti L; Morbelli S; Nobili F
    Clin Nucl Med; 2021 Jun; 46(6):e327-e328. PubMed ID: 33630801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.